SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $236,069 | -99.9% | 266,443 | 0.0% | 0.00% | – |
Q3 2022 | $418,316,000 | -21.9% | 266,443 | 0.0% | 0.00% | – |
Q2 2022 | $535,550,000 | -10.3% | 266,443 | +3.9% | 0.00% | – |
Q1 2022 | $597,280,000 | -49.9% | 256,343 | 0.0% | 0.00% | – |
Q4 2021 | $1,191,996,000 | -48.3% | 256,343 | -15.1% | 0.00% | -100.0% |
Q3 2021 | $2,303,483,000 | -23.4% | 301,898 | -2.7% | 0.00% | 0.0% |
Q2 2021 | $3,006,817,000 | +58.8% | 310,301 | +35.6% | 0.00% | 0.0% |
Q1 2021 | $1,892,994,000 | +26.1% | 228,899 | +4.0% | 0.00% | 0.0% |
Q4 2020 | $1,501,608,000 | +11.3% | 220,016 | +81.8% | 0.00% | 0.0% |
Q3 2020 | $1,349,440,000 | +86.1% | 121,026 | +4.8% | 0.00% | – |
Q2 2020 | $725,233,000 | +594.4% | 115,483 | +136.6% | 0.00% | – |
Q3 2019 | $104,434,000 | -26.1% | 48,801 | -7.7% | 0.00% | – |
Q2 2019 | $141,232,000 | -21.7% | 52,896 | +39.4% | 0.00% | – |
Q1 2019 | $180,277,000 | +120.6% | 37,953 | +11.5% | 0.00% | – |
Q4 2018 | $81,728,000 | -14.0% | 34,053 | +57.7% | 0.00% | – |
Q3 2018 | $95,040,000 | -38.9% | 21,600 | 0.0% | 0.00% | – |
Q2 2018 | $155,520,000 | – | 21,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
TRUST CO OF VERMONT | 204 | $19 | 0.00% |
SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |